🔴 Moderna is trading 4.01% down today amid broader biotech weakness and rising yields

Moderna is trading 4.01% down at $46.18 as shares extend a multi-day slide, tracking broader biotech weakness and a risk-off market environment.

• Higher Treasury yields are pressuring growth-oriented names, contributing to the downward momentum across the sector.
• No major company-specific announcements appear tied to the move, suggesting market sentiment and momentum are the primary drivers.
• The stock continues its recent soft streak after closing at $48.11 on May 18 and $49.04 on May 15.